Zhi-Jian Chen
Research Subjects
Research Interests
Zhi-Jian Chen has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
Qi-Huang Gong
7 shared publicationsAndrzej Przekwas
4 shared publicationsBo-Wei Xu
4 shared publications- Lixin Xiao
Peking University
4 shared publications Yu-Mei Zhang
4 shared publicationsBo Qu
3 shared publications
Latest Publications
- 1 January 2015
- Published by Elsevier in Journal of Computational Physics
- Vol. 281, 690-707
A high-order CFD method using successive differentiation
- 1 January 2015
- Published by Elsevier in Journal of Computational Physics
- Vol. 281, 690-707
A high-order CFD method using successive differentiation
- 20 April 2013
- Published by China Science Publishing & Media Ltd. in Journal of Electronics & Information Technology
- Vol. 35 (4) , 1001-1006
Branch Prediction Based on Dynamic Polarity Transformation
- 20 April 2013
- Published by China Science Publishing & Media Ltd. in Journal of Electronics & Information Technology
- Vol. 35 (4) , 1001-1006
Branch Prediction Based on Dynamic Polarity Transformation
- 1 February 2013
- Vol. 33 (2) , 289-92
[Organic solar cell based on alkylthiol/Au self-assembly film as buffer layer].
The interface modification between the organic active layer and the inorganic electrode affects the performance of organic solar cell (OSC). A buffer layer of alkylthiol (ethanethiol, hexanethiol, dodecanethiol)/Au self-assembly layer was introduced into OSC to substitute Poly(3,4-ethylenedioxythiophene) : poly(styrene sulfonate) (PEDOT : PSS) layer, in order to improve the organic/inorganic interface. We fabricated devices with structure of "ITO/Au (annealed Au film of 2 nm)-thiol self assembly layer/poly(3-hexylthiophene) : 1-(3-methoxycarbonyl) -propyl-1-phenyl-(6,6)C61(P3HT : PCBM) /LiF/Al". After alkanethiol self-assembling, the alkanethiol prevented exciton quenching owe to direct contact between the Au NPs and the active layer. We studied the impact of alkanethiol with different chain length on device performance. With? the? growth? of? the? alkyl chain, the coverage of the thiol on Au NPs got better, and the device performance become better. In the OSC with dodecane-thiol/Au (2 nm Au film annealed) self-assembly film, the short-circuit current increases from 5.19 mA x cm(-2) to 6.24 mA x cm(-2).
- 1 February 2013
- Vol. 33 (2) , 289-92
[Organic solar cell based on alkylthiol/Au self-assembly film as buffer layer].
The interface modification between the organic active layer and the inorganic electrode affects the performance of organic solar cell (OSC). A buffer layer of alkylthiol (ethanethiol, hexanethiol, dodecanethiol)/Au self-assembly layer was introduced into OSC to substitute Poly(3,4-ethylenedioxythiophene) : poly(styrene sulfonate) (PEDOT : PSS) layer, in order to improve the organic/inorganic interface. We fabricated devices with structure of "ITO/Au (annealed Au film of 2 nm)-thiol self assembly layer/poly(3-hexylthiophene) : 1-(3-methoxycarbonyl) -propyl-1-phenyl-(6,6)C61(P3HT : PCBM) /LiF/Al". After alkanethiol self-assembling, the alkanethiol prevented exciton quenching owe to direct contact between the Au NPs and the active layer. We studied the impact of alkanethiol with different chain length on device performance. With? the? growth? of? the? alkyl chain, the coverage of the thiol on Au NPs got better, and the device performance become better. In the OSC with dodecane-thiol/Au (2 nm Au film annealed) self-assembly film, the short-circuit current increases from 5.19 mA x cm(-2) to 6.24 mA x cm(-2).
- 1 October 2012
- Vol. 32 (10) , 2597-600
[Infrared multiphoton quantum cutting phenomena of rare earth materials].
Infrared quantum cutting of rare earth ion is an international hot research field. It is significant for the enhancement of solar cell efficiency and for the reduction of solar cell price. The present paper summarizes the research significance of infrared quantum cutting of rare earth ion. Based on the summarization of general principle and loss mechanism of solar cell, the possible method to enhance the solar cell efficiency by infrared quantum cutting is analyzed. Meanwhile, the present paper summarizes the infrared quantum cutting phenomena of Er3+ ion single-doped material. There is intense 4I13/2 --> 4I15/2 infrared quantum cutting luminescence of Er3+ ion when the 2H11/2 energy level is excited. The intense {2H11/2 --> 4I9/2, 4I15/2 --> 4I13/2} cross energy transfer is the main reason for the result in the high quantum cutting efficiency when the 2H11/2 energy level is excited.
- 1 October 2012
- Vol. 32 (10) , 2597-600
[Infrared multiphoton quantum cutting phenomena of rare earth materials].
Infrared quantum cutting of rare earth ion is an international hot research field. It is significant for the enhancement of solar cell efficiency and for the reduction of solar cell price. The present paper summarizes the research significance of infrared quantum cutting of rare earth ion. Based on the summarization of general principle and loss mechanism of solar cell, the possible method to enhance the solar cell efficiency by infrared quantum cutting is analyzed. Meanwhile, the present paper summarizes the infrared quantum cutting phenomena of Er3+ ion single-doped material. There is intense 4I13/2 --> 4I15/2 infrared quantum cutting luminescence of Er3+ ion when the 2H11/2 energy level is excited. The intense {2H11/2 --> 4I9/2, 4I15/2 --> 4I13/2} cross energy transfer is the main reason for the result in the high quantum cutting efficiency when the 2H11/2 energy level is excited.
- 17 April 2012
- Vol. 92 (15) , 1028-32
[A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis].
To evaluate the safety and validity of neo-adjuvant chemoradiotherapy followed by surgery for locally advanced esophageal carcinoma. Patients with IIB, III staged squamous cell carcinoma of thoracic esophagus were randomly allocated to either preoperative chemoradiotherapy followed by surgery (arm A) or surgery alone (arm B). In arm A, chemotherapy and radiotherapy were performed concurrently. Patients received two cycles of vinorelbine and cisplatin. Vinorelbine at 25 mg/m(2) per day was administered as a bolus infusion at d1, d8, d22 and d29. Cisplatin at 75 mg/m(2) was administered by an intravenous infusion at d1 and d22 (or 25 mg/m(2) days 1 - 4 and 22 - 25). A total radiotherapeutic dose of 40 Gy was delivered in 20 daily fractions of 2.0 Gy each (5 d/wk for 4 weeks). Three-incisioned esophagectomy was performed at Weeks 4 - 6 after chemoradiotherapy. Primary outcome was overall survival time. An interim analysis was performed in June 2011. From July 2007 to June 2011, 123 eligible patients were randomly assigned at 7 cooperative cancer centers (54 cases in arm A vs 69 cases in arm B). In arm A, the clinical response rate of chemoradiotherapy was 90.7%. All patients finished the preoperative chemoradiotherapy. Forty-nine cases continued to receive esophagectomy. The pathological complete response rate was 29.6%. The rate of R0 resection in arm A was significant higher than that in arm B(96.0% vs 85.5%, P = 0.015). The most common grade 3/4 toxicity of chemoradiotherapy was leukopenia occurring in 33 cases (61.1%). Vomiting and esophagitis were usually of Grade 1/2. No patient died or abandoned surgery because of chemoradiation toxicity. Between arms A and B, operative duration, blood loss, duration of chest tube drainage and length of postsurgical hospital stay were similar. The incidences of postoperative heart failure (2.0% vs 1.4%, P = 1.000), anastomotic leakage (8.2% vs 11.6%, P = 0.759) and hoarseness (6.1% vs 4.3%, P = 0.691) were not significantly different. The incidence of pulmonary infection in arm A was slightly higher than that in arm B (8.2% vs 1.4%, P = 0.094). No perioperative deaths occurred in either group. There were no significant differences in overall survivals at 1, 2 years between arms A and B (85.6%/75.5% vs 79.1%/66.1%, P = 0.207). The disease-free survivals at 1, 2 years in arm A were slightly higher than in arm B (86.6%/83.2% vs 70.9%/61.8%, P = 0.075). Neo-adjuvant chemoradiation followed by surgery may achieve a high clinical response rate and pathologic complete tumor regression rate. It significantly increases the R0 resection rate and down stage the esophageal cancer patients. But its ultimate efficacy awaits further follow-up studies.
- 17 April 2012
- Vol. 92 (15) , 1028-32
[A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis].
To evaluate the safety and validity of neo-adjuvant chemoradiotherapy followed by surgery for locally advanced esophageal carcinoma. Patients with IIB, III staged squamous cell carcinoma of thoracic esophagus were randomly allocated to either preoperative chemoradiotherapy followed by surgery (arm A) or surgery alone (arm B). In arm A, chemotherapy and radiotherapy were performed concurrently. Patients received two cycles of vinorelbine and cisplatin. Vinorelbine at 25 mg/m(2) per day was administered as a bolus infusion at d1, d8, d22 and d29. Cisplatin at 75 mg/m(2) was administered by an intravenous infusion at d1 and d22 (or 25 mg/m(2) days 1 - 4 and 22 - 25). A total radiotherapeutic dose of 40 Gy was delivered in 20 daily fractions of 2.0 Gy each (5 d/wk for 4 weeks). Three-incisioned esophagectomy was performed at Weeks 4 - 6 after chemoradiotherapy. Primary outcome was overall survival time. An interim analysis was performed in June 2011. From July 2007 to June 2011, 123 eligible patients were randomly assigned at 7 cooperative cancer centers (54 cases in arm A vs 69 cases in arm B). In arm A, the clinical response rate of chemoradiotherapy was 90.7%. All patients finished the preoperative chemoradiotherapy. Forty-nine cases continued to receive esophagectomy. The pathological complete response rate was 29.6%. The rate of R0 resection in arm A was significant higher than that in arm B(96.0% vs 85.5%, P = 0.015). The most common grade 3/4 toxicity of chemoradiotherapy was leukopenia occurring in 33 cases (61.1%). Vomiting and esophagitis were usually of Grade 1/2. No patient died or abandoned surgery because of chemoradiation toxicity. Between arms A and B, operative duration, blood loss, duration of chest tube drainage and length of postsurgical hospital stay were similar. The incidences of postoperative heart failure (2.0% vs 1.4%, P = 1.000), anastomotic leakage (8.2% vs 11.6%, P = 0.759) and hoarseness (6.1% vs 4.3%, P = 0.691) were not significantly different. The incidence of pulmonary infection in arm A was slightly higher than that in arm B (8.2% vs 1.4%, P = 0.094). No perioperative deaths occurred in either group. There were no significant differences in overall survivals at 1, 2 years between arms A and B (85.6%/75.5% vs 79.1%/66.1%, P = 0.207). The disease-free survivals at 1, 2 years in arm A were slightly higher than in arm B (86.6%/83.2% vs 70.9%/61.8%, P = 0.075). Neo-adjuvant chemoradiation followed by surgery may achieve a high clinical response rate and pathologic complete tumor regression rate. It significantly increases the R0 resection rate and down stage the esophageal cancer patients. But its ultimate efficacy awaits further follow-up studies.
- 15 April 2012
- Published by American Association for Cancer Research (AACR)
- Vol. 72 (8) , LB-72
Abstract LB-72: A20 ubiquitin ligase-mediated RIP1 polyubiquitin chains inhibits TRAIL-induced apoptosis in glioblastoma
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) apoptotic pathway has emerged as a cancer therapeutic target; however, clinical trials have proven that the vast majority of human cancers are resistant to TRAIL apoptotic pathway-targeted therapies. We show here that A20-mediated ubiquitination inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma through two signaling complexes. A20 is highly expressed in glioblastomas and, together with the death receptor 5 (DR5) and receptor-interacting protein 1 (RIP1), forms a DR5-associated plasma membrane bound signaling complex that we named the preligand assembly complex (PLAC) under physiologic conditions. TRAIL treatment leads to the recruitment of caspase-8 to the PLAC for the assembly of a death-inducing signaling complex (DISC). In the DISC, the C-terminal Zinc finger domain of the A20 ubiquitin ligase mediates RIP1 ubiquitination through lysine (K)-63-linked polyubiquitin chains, which bind to the protease domain of caspase-8 and inhibits its dimerization, cleavage and the initiation of TRAIL-induced apoptosis in glioblastoma-derived cell lines and tumor-initiating cells. These results identify A20 ubiquitin ligase as a therapeutic target whose inhibition can overcome TRAIL resistance in glioblastoma and thus have an impact on ongoing clinical trials of TRAIL apoptotic pathway-targeted combination cancer therapies (the manuscript was published online first in Cancer Discovery). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-72. doi:1538-7445.AM2012-LB-72
- 15 April 2012
- Published by American Association for Cancer Research (AACR)
- Vol. 72 (8) , LB-72
Abstract LB-72: A20 ubiquitin ligase-mediated RIP1 polyubiquitin chains inhibits TRAIL-induced apoptosis in glioblastoma
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) apoptotic pathway has emerged as a cancer therapeutic target; however, clinical trials have proven that the vast majority of human cancers are resistant to TRAIL apoptotic pathway-targeted therapies. We show here that A20-mediated ubiquitination inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma through two signaling complexes. A20 is highly expressed in glioblastomas and, together with the death receptor 5 (DR5) and receptor-interacting protein 1 (RIP1), forms a DR5-associated plasma membrane bound signaling complex that we named the preligand assembly complex (PLAC) under physiologic conditions. TRAIL treatment leads to the recruitment of caspase-8 to the PLAC for the assembly of a death-inducing signaling complex (DISC). In the DISC, the C-terminal Zinc finger domain of the A20 ubiquitin ligase mediates RIP1 ubiquitination through lysine (K)-63-linked polyubiquitin chains, which bind to the protease domain of caspase-8 and inhibits its dimerization, cleavage and the initiation of TRAIL-induced apoptosis in glioblastoma-derived cell lines and tumor-initiating cells. These results identify A20 ubiquitin ligase as a therapeutic target whose inhibition can overcome TRAIL resistance in glioblastoma and thus have an impact on ongoing clinical trials of TRAIL apoptotic pathway-targeted combination cancer therapies (the manuscript was published online first in Cancer Discovery). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-72. doi:1538-7445.AM2012-LB-72
- 3 March 2012
- Published by ASME International
- p. 85-93
Physics Based Simulation of Large Size Particle Transport in Biomedical Applications
In biomedical microdevices and medical applications there is a need to analyze fluid transport of solid structures with sizes comparable to channel dimensions. Examples include manipulation of biological cells in microfluidic devices or transport of thrombin particles in blood vessels. Computational modeling of such macroparticles is very difficult when the particle size is bigger than the size of the computational control volume (mesh element). In performing such simulations, conventional Lagrangian model of micro particles is not suitable since this approach doesn’t account particle’s volume blockage of the supporting Eulerian computational mesh. Other approaches such as deforming mesh or volume of fluid are either impractical of computationally very intensive or limited to structured meshes. We have developed a ‘macroparticle’ methodology where the large particle is represented as a large cluster of smaller particles (marker particles) that is “embedded” on a background computational grid. The macroparticle is then represented by blocking the cells in the background mesh that are overlapped by individual micro-particles. The discrete surface of the macroparticle is represented by partially or fully blocked cells of the background computational mesh. The translation /rotation/deformation motion of the macroparticle is calculated using a 6-DOF model with fluid pressure and shear forces acting on the particle surface used as forces and moments in calculating macroparticle position, velocity, acceleration and rotation. The size of the background grid determines the accuracy of the particle shape definition and the flow solution. The relevant physics and chemical conservation laws for each macroparticle are solved in a coupled, iterative method with the equation systems governing the background fluid domain. This methodology has been successfully used for simulations of macroparticle-laden fluids in micro channels in biochips. As an application of this novel method, we have applied this technology to simulate a moving clot in blood flow and process of clot mechanical dissolution (thrombolysis).
- 3 March 2012
- Published by ASME International
- p. 85-93
Physics Based Simulation of Large Size Particle Transport in Biomedical Applications
In biomedical microdevices and medical applications there is a need to analyze fluid transport of solid structures with sizes comparable to channel dimensions. Examples include manipulation of biological cells in microfluidic devices or transport of thrombin particles in blood vessels. Computational modeling of such macroparticles is very difficult when the particle size is bigger than the size of the computational control volume (mesh element). In performing such simulations, conventional Lagrangian model of micro particles is not suitable since this approach doesn’t account particle’s volume blockage of the supporting Eulerian computational mesh. Other approaches such as deforming mesh or volume of fluid are either impractical of computationally very intensive or limited to structured meshes. We have developed a ‘macroparticle’ methodology where the large particle is represented as a large cluster of smaller particles (marker particles) that is “embedded” on a background computational grid. The macroparticle is then represented by blocking the cells in the background mesh that are overlapped by individual micro-particles. The discrete surface of the macroparticle is represented by partially or fully blocked cells of the background computational mesh. The translation /rotation/deformation motion of the macroparticle is calculated using a 6-DOF model with fluid pressure and shear forces acting on the particle surface used as forces and moments in calculating macroparticle position, velocity, acceleration and rotation. The size of the background grid determines the accuracy of the particle shape definition and the flow solution. The relevant physics and chemical conservation laws for each macroparticle are solved in a coupled, iterative method with the equation systems governing the background fluid domain. This methodology has been successfully used for simulations of macroparticle-laden fluids in micro channels in biochips. As an application of this novel method, we have applied this technology to simulate a moving clot in blood flow and process of clot mechanical dissolution (thrombolysis).
- 20 June 2011
- Published by China Science Publishing & Media Ltd. in Journal of Computer Applications
- Vol. 31 (6) , 1502-1504
Self-adaptive image encryption algorithm based on chaotic map
- 20 June 2011
- Published by China Science Publishing & Media Ltd. in Journal of Computer Applications
- Vol. 31 (6) , 1502-1504
Self-adaptive image encryption algorithm based on chaotic map
- 1 May 2011
- Vol. 31 (5) , 1161-7
[Improvement of the power conversion efficiency in organic solar cells].
Energy is most important issue in the world now because the chemical energy (oil, natural gas, coal et al) is on the edge of depleting. Many Countries are now paying attention to the use of sun power. Photovoltaic device is the most important way to make use of sun energy. Organic solar cell is one promising kind of photovoltaic device, though it's low power conversion efficiency hampers its commercialization. This paper briefly reviewed two ways to improve the power conversion efficiency of organic solar cells and pointed out the unsolved problems.
- 1 May 2011
- Vol. 31 (5) , 1161-7
[Improvement of the power conversion efficiency in organic solar cells].
Energy is most important issue in the world now because the chemical energy (oil, natural gas, coal et al) is on the edge of depleting. Many Countries are now paying attention to the use of sun power. Photovoltaic device is the most important way to make use of sun energy. Organic solar cell is one promising kind of photovoltaic device, though it's low power conversion efficiency hampers its commercialization. This paper briefly reviewed two ways to improve the power conversion efficiency of organic solar cells and pointed out the unsolved problems.